array(40) {
  [0]=>
  string(4) "9148"
  ["article_id"]=>
  string(4) "9148"
  [1]=>
  string(171) "Press release Biocartis Group NV: Disclosure of transparency notification  (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)"
  ["article_title"]=>
  string(171) "Press release Biocartis Group NV: Disclosure of transparency notification  (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)"
  [2]=>
  string(45) "BIOCARTIS GROUP NV (Euronext Brussels: BCART)"
  ["short_description"]=>
  string(45) "BIOCARTIS GROUP NV (Euronext Brussels: BCART)"
  [3]=>
  string(77) "

BIOCARTIS GROUP NV (Euronext Brussels: BCART)
"
  ["description"]=>
  string(77) "

BIOCARTIS GROUP NV (Euronext Brussels: BCART)
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(237) "https://www.globenewswire.com/news-release/2024/01/10/2807542/0/en/Press-release-Biocartis-Group-NV-Disclosure-of-transparency-notification-Article-14-first-paragraph-of-the-Act-of-2-May-2007-on-the-disclosure-of-major-shareholdings.html"
  ["blog_url"]=>
  string(237) "https://www.globenewswire.com/news-release/2024/01/10/2807542/0/en/Press-release-Biocartis-Group-NV-Disclosure-of-transparency-notification-Article-14-first-paragraph-of-the-Act-of-2-May-2007-on-the-disclosure-of-major-shareholdings.html"
  [15]=>
  string(19) "2024-01-11 06:00:00"
  ["add_date"]=>
  string(19) "2024-01-11 06:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:29"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:29"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9093"
  ["article_id"]=>
  string(4) "9093"
  [1]=>
  string(133) "Open Enrollment Commences for Phase 1b/2 Study Evaluating Ampligen in Combination with Imfinzi for the Treatment of Pancreatic Cancer"
  ["article_title"]=>
  string(133) "Open Enrollment Commences for Phase 1b/2 Study Evaluating Ampligen in Combination with Imfinzi for the Treatment of Pancreatic Cancer"
  [2]=>
  string(150) "OCALA, Fla., Jan. 10, 2024. AIM ImmunoTech Inc. (“AIM” or the “Company”) today announced that enrollment is open at Erasmus Me"
  ["short_description"]=>
  string(150) "OCALA, Fla., Jan. 10, 2024. AIM ImmunoTech Inc. (“AIM” or the “Company”) today announced that enrollment is open at Erasmus Me"
  [3]=>
  string(245) "OCALA, Fla., Jan. 10, 2024. AIM ImmunoTech Inc. (“AIM” or the “Company”) today announced that enrollment is open at Erasmus Medical Center (“Erasmus MC”) in a Phase 1b/2 clinical trial combining AIM’s..."
  ["description"]=>
  string(245) "OCALA, Fla., Jan. 10, 2024. AIM ImmunoTech Inc. (“AIM” or the “Company”) today announced that enrollment is open at Erasmus Medical Center (“Erasmus MC”) in a Phase 1b/2 clinical trial combining AIM’s..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(149) "https://www.drugs.com/clinical_trials/open-enrollment-commences-phase-1b-2-study-evaluating-ampligen-combination-imfinzi-pancreatic-cancer-21267.html"
  ["blog_url"]=>
  string(149) "https://www.drugs.com/clinical_trials/open-enrollment-commences-phase-1b-2-study-evaluating-ampligen-combination-imfinzi-pancreatic-cancer-21267.html"
  [15]=>
  string(19) "2024-01-11 04:01:03"
  ["add_date"]=>
  string(19) "2024-01-11 04:01:03"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9094"
  ["article_id"]=>
  string(4) "9094"
  [1]=>
  string(90) "Reduced Drug Use is a Meaningful Treatment Outcome for People with Stimulant Use Disorders"
  ["article_title"]=>
  string(90) "Reduced Drug Use is a Meaningful Treatment Outcome for People with Stimulant Use Disorders"
  [2]=>
  string(150) "January 10, 2024 -- Reducing stimulant use was associated with significant improvement in measures of health and recovery among people with stimulant "
  ["short_description"]=>
  string(150) "January 10, 2024 -- Reducing stimulant use was associated with significant improvement in measures of health and recovery among people with stimulant "
  [3]=>
  string(245) "January 10, 2024 -- Reducing stimulant use was associated with significant improvement in measures of health and recovery among people with stimulant use disorder, even if they did not achieve total abstinence. This finding is according to an..."
  ["description"]=>
  string(245) "January 10, 2024 -- Reducing stimulant use was associated with significant improvement in measures of health and recovery among people with stimulant use disorder, even if they did not achieve total abstinence. This finding is according to an..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(95) "https://www.drugs.com/clinical_trials/reduced-meaningful-outcome-stimulant-disorders-21271.html"
  ["blog_url"]=>
  string(95) "https://www.drugs.com/clinical_trials/reduced-meaningful-outcome-stimulant-disorders-21271.html"
  [15]=>
  string(19) "2024-01-11 03:01:20"
  ["add_date"]=>
  string(19) "2024-01-11 03:01:20"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9149"
  ["article_id"]=>
  string(4) "9149"
  [1]=>
  string(55) "The Peer Group Now Offers Glo2Facial Treatment by Geneo"
  ["article_title"]=>
  string(55) "The Peer Group Now Offers Glo2Facial Treatment by Geneo"
  [2]=>
  string(150) "Refresh Your Skin with an Advanced Professional Facial That Combines Exfoliation and Oxygenation from the Northern New Jersey Team Refresh Your Skin w"
  ["short_description"]=>
  string(150) "Refresh Your Skin with an Advanced Professional Facial That Combines Exfoliation and Oxygenation from the Northern New Jersey Team Refresh Your Skin w"
  [3]=>
  string(272) "Refresh Your Skin with an Advanced Professional Facial That Combines Exfoliation and Oxygenation from the Northern New Jersey Team 
Refresh Your Skin with an Advanced Professional Facial That Combines Exfoliation and Oxygenation from the Northern New Jersey Team
"
  ["description"]=>
  string(272) "Refresh Your Skin with an Advanced Professional Facial That Combines Exfoliation and Oxygenation from the Northern New Jersey Team 
Refresh Your Skin with an Advanced Professional Facial That Combines Exfoliation and Oxygenation from the Northern New Jersey Team
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(127) "https://www.globenewswire.com/news-release/2024/01/10/2807428/0/en/The-Peer-Group-Now-Offers-Glo2Facial-Treatment-by-Geneo.html"
  ["blog_url"]=>
  string(127) "https://www.globenewswire.com/news-release/2024/01/10/2807428/0/en/The-Peer-Group-Now-Offers-Glo2Facial-Treatment-by-Geneo.html"
  [15]=>
  string(19) "2024-01-11 02:35:00"
  ["add_date"]=>
  string(19) "2024-01-11 02:35:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:29"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:29"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9238"
  ["article_id"]=>
  string(4) "9238"
  [1]=>
  string(91) "Virtual group therapy enables Geisinger to treat more patients and maintain care continuity"
  ["article_title"]=>
  string(91) "Virtual group therapy enables Geisinger to treat more patients and maintain care continuity"
  [2]=>
  string(150) "With waits for individual psychotherapy as long as several months and several thousand outstanding orders, the mostly rural health system needed a sol"
  ["short_description"]=>
  string(150) "With waits for individual psychotherapy as long as several months and several thousand outstanding orders, the mostly rural health system needed a sol"
  [3]=>
  string(217) "With waits for individual psychotherapy as long as several months and several thousand outstanding orders, the mostly rural health system needed a solution. Combining group therapy and telemedicine was the answer.&#nl"
  ["description"]=>
  string(217) "With waits for individual psychotherapy as long as several months and several thousand outstanding orders, the mostly rural health system needed a solution. Combining group therapy and telemedicine was the answer.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(126) "https://www.healthcareitnews.com/news/virtual-group-therapy-enables-geisinger-treat-more-patients-and-maintain-care-continuity"
  ["blog_url"]=>
  string(126) "https://www.healthcareitnews.com/news/virtual-group-therapy-enables-geisinger-treat-more-patients-and-maintain-care-continuity"
  [15]=>
  string(19) "2024-01-11 01:49:02"
  ["add_date"]=>
  string(19) "2024-01-11 01:49:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9275"
  ["article_id"]=>
  string(4) "9275"
  [1]=>
  string(85) "FDA Announces Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge Winners"
  ["article_title"]=>
  string(85) "FDA Announces Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge Winners"
  [2]=>
  string(154) "“The V-CHAMPS Challenge showed us that artificial intelligence (AI) models that performed well on the synthetic patient data in Phase 1 also perform"
  ["short_description"]=>
  string(154) "“The V-CHAMPS Challenge showed us that artificial intelligence (AI) models that performed well on the synthetic patient data in Phase 1 also perform"
  [3]=>
  string(638) "
“The V-CHAMPS Challenge showed us that artificial intelligence (AI) models that performed well on the synthetic patient data in Phase 1 also performed well on the RWD during Phase 2, highlighting the potential value of using synthetic data in AI model development.”
&#nl
The post FDA Announces Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge Winners appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(638) "
“The V-CHAMPS Challenge showed us that artificial intelligence (AI) models that performed well on the synthetic patient data in Phase 1 also performed well on the RWD during Phase 2, highlighting the potential value of using synthetic data in AI model development.”
&#nl
The post FDA Announces Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge Winners appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(126) "https://medtechintelligence.com/news_article/fda-announces-cardiac-health-and-ai-model-predictions-v-champs-challenge-winners/"
  ["blog_url"]=>
  string(126) "https://medtechintelligence.com/news_article/fda-announces-cardiac-health-and-ai-model-predictions-v-champs-challenge-winners/"
  [15]=>
  string(19) "2024-01-11 01:40:06"
  ["add_date"]=>
  string(19) "2024-01-11 01:40:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:30"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:30"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9276"
  ["article_id"]=>
  string(4) "9276"
  [1]=>
  string(79) "FDA Approves Medtronic Percept RC Neurostimulator for Deep Brain Stimulation"
  ["article_title"]=>
  string(79) "FDA Approves Medtronic Percept RC Neurostimulator for Deep Brain Stimulation"
  [2]=>
  string(150) "The surgically implanted neurostimulators transmit electrical signals to specific brain targets affected by neurological disorders to control tremors."
  ["short_description"]=>
  string(150) "The surgically implanted neurostimulators transmit electrical signals to specific brain targets affected by neurological disorders to control tremors."
  [3]=>
  string(683) "
The surgically implanted neurostimulators transmit electrical signals to specific brain targets affected by neurological disorders to control tremors. The Percept RC is equipped with BrainSense technology that captures and records brain signals to provide insights that enable a healthcare provider to adapt and personalize therapy.
&#nl
The post FDA Approves Medtronic Percept RC Neurostimulator for Deep Brain Stimulation appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(683) "
The surgically implanted neurostimulators transmit electrical signals to specific brain targets affected by neurological disorders to control tremors. The Percept RC is equipped with BrainSense technology that captures and records brain signals to provide insights that enable a healthcare provider to adapt and personalize therapy.
&#nl
The post FDA Approves Medtronic Percept RC Neurostimulator for Deep Brain Stimulation appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(122) "https://medtechintelligence.com/news_article/fda-approves-medtronic-percept-rc-neurostimulator-for-deep-brain-stimulation/"
  ["blog_url"]=>
  string(122) "https://medtechintelligence.com/news_article/fda-approves-medtronic-percept-rc-neurostimulator-for-deep-brain-stimulation/"
  [15]=>
  string(19) "2024-01-11 01:18:27"
  ["add_date"]=>
  string(19) "2024-01-11 01:18:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:30"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:30"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9150"
  ["article_id"]=>
  string(4) "9150"
  [1]=>
  string(96) "LifeLabs Scores Back-to-Back Win: Named 2024 BrandSpark Most Trusted for Second Consecutive Year"
  ["article_title"]=>
  string(96) "LifeLabs Scores Back-to-Back Win: Named 2024 BrandSpark Most Trusted for Second Consecutive Year"
  [2]=>
  string(155) "Toronto, Jan.  10, 2024  (GLOBE NEWSWIRE) -- LifeLabs is proud to announce our achievement for the second consecutive year – securing the 2024 Brand"
  ["short_description"]=>
  string(155) "Toronto, Jan.  10, 2024  (GLOBE NEWSWIRE) -- LifeLabs is proud to announce our achievement for the second consecutive year – securing the 2024 Brand"
  [3]=>
  string(223) "
Toronto, Jan.  10, 2024  (GLOBE NEWSWIRE) -- LifeLabs is proud to announce our achievement for the second consecutive year – securing the 2024 BrandSpark Most Trusted Brand Award in Health Diagnostic Services.
"
  ["description"]=>
  string(223) "
Toronto, Jan.  10, 2024  (GLOBE NEWSWIRE) -- LifeLabs is proud to announce our achievement for the second consecutive year – securing the 2024 BrandSpark Most Trusted Brand Award in Health Diagnostic Services.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(167) "https://www.globenewswire.com/news-release/2024/01/10/2807367/0/en/LifeLabs-Scores-Back-to-Back-Win-Named-2024-BrandSpark-Most-Trusted-for-Second-Consecutive-Year.html"
  ["blog_url"]=>
  string(167) "https://www.globenewswire.com/news-release/2024/01/10/2807367/0/en/LifeLabs-Scores-Back-to-Back-Win-Named-2024-BrandSpark-Most-Trusted-for-Second-Consecutive-Year.html"
  [15]=>
  string(19) "2024-01-11 00:44:00"
  ["add_date"]=>
  string(19) "2024-01-11 00:44:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:29"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:29"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9277"
  ["article_id"]=>
  string(4) "9277"
  [1]=>
  string(63) "MHRA Releases Roadmap of Future UK Medical Device Regulation"
  ["article_title"]=>
  string(63) "MHRA Releases Roadmap of Future UK Medical Device Regulation"
  [2]=>
  string(159) "“The new framework will strengthen the MHRA’s ability to keep patients safe, while at the same time contributing to an environment which encourage"
  ["short_description"]=>
  string(159) "“The new framework will strengthen the MHRA’s ability to keep patients safe, while at the same time contributing to an environment which encourage"
  [3]=>
  string(706) "
“The new framework will strengthen the MHRA’s ability to keep patients safe, while at the same time contributing to an environment which encourages the launch of the most innovative healthcare products that make a real difference to the public’s health. The roadmap sets out how we will work with stakeholders, including patients, as the process moves forward.”
&#nl
The post MHRA Releases Roadmap of Future UK Medical Device Regulation appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(706) "
“The new framework will strengthen the MHRA’s ability to keep patients safe, while at the same time contributing to an environment which encourages the launch of the most innovative healthcare products that make a real difference to the public’s health. The roadmap sets out how we will work with stakeholders, including patients, as the process moves forward.”
&#nl
The post MHRA Releases Roadmap of Future UK Medical Device Regulation appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(106) "https://medtechintelligence.com/news_article/mhra-releases-roadmap-of-future-uk-medical-device-regulation/"
  ["blog_url"]=>
  string(106) "https://medtechintelligence.com/news_article/mhra-releases-roadmap-of-future-uk-medical-device-regulation/"
  [15]=>
  string(19) "2024-01-11 00:21:14"
  ["add_date"]=>
  string(19) "2024-01-11 00:21:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:30"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:30"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9194"
  ["article_id"]=>
  string(4) "9194"
  [1]=>
  string(60) "TekniPlex Healthcare to debut PET blister film at Pharmapack"
  ["article_title"]=>
  string(60) "TekniPlex Healthcare to debut PET blister film at Pharmapack"
  [2]=>
  string(163) "TekniPlex Healthcare has partnered with petrochemical specialist Alpek Polyester to introduce the "world’s first" pharmaceutical-grade polyethylene "
  ["short_description"]=>
  string(163) "TekniPlex Healthcare has partnered with petrochemical specialist Alpek Polyester to introduce the "world’s first" pharmaceutical-grade polyethylene "
  [3]=>
  string(224) "TekniPlex Healthcare has partnered with petrochemical specialist Alpek Polyester to introduce the "world’s first" pharmaceutical-grade polyethylene terephthalate (PET) blister film containing recycled content."
  ["description"]=>
  string(224) "TekniPlex Healthcare has partnered with petrochemical specialist Alpek Polyester to introduce the "world’s first" pharmaceutical-grade polyethylene terephthalate (PET) blister film containing recycled content."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(139) "https://www.medicalplasticsnews.com/news/medical-plastics-sustainability-news/tekniplex-healthcare-to-debut-recyclable-pet-blister-film-at/"
  ["blog_url"]=>
  string(139) "https://www.medicalplasticsnews.com/news/medical-plastics-sustainability-news/tekniplex-healthcare-to-debut-recyclable-pet-blister-film-at/"
  [15]=>
  string(19) "2024-01-11 00:20:00"
  ["add_date"]=>
  string(19) "2024-01-11 00:20:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:42"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9239"
  ["article_id"]=>
  string(4) "9239"
  [1]=>
  string(43) "Mayo Clinic taps AI start-up to unlock data"
  ["article_title"]=>
  string(43) "Mayo Clinic taps AI start-up to unlock data"
  [2]=>
  string(139) "The health system has partnered with Cerebras to develop artificial intelligence models based on decades of anonymized medical records.&#nl"
  ["short_description"]=>
  string(139) "The health system has partnered with Cerebras to develop artificial intelligence models based on decades of anonymized medical records.&#nl"
  [3]=>
  string(139) "The health system has partnered with Cerebras to develop artificial intelligence models based on decades of anonymized medical records.&#nl"
  ["description"]=>
  string(139) "The health system has partnered with Cerebras to develop artificial intelligence models based on decades of anonymized medical records.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(75) "https://www.healthcareitnews.com/news/mayo-clinic-taps-ai-start-unlock-data"
  ["blog_url"]=>
  string(75) "https://www.healthcareitnews.com/news/mayo-clinic-taps-ai-start-unlock-data"
  [15]=>
  string(19) "2024-01-10 23:59:52"
  ["add_date"]=>
  string(19) "2024-01-10 23:59:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9212"
  ["article_id"]=>
  string(4) "9212"
  [1]=>
  string(102) "Fortrea, Advarra and Veeva form partnership to 'dramatically simplify' clinical trial process "
  ["article_title"]=>
  string(102) "Fortrea, Advarra and Veeva form partnership to 'dramatically simplify' clinical trial process "
  [2]=>
  string(150) "Global contract research organization (CRO), Fortrea today announced an industry partnership with founding members cloud solutions company Veeva Syste"
  ["short_description"]=>
  string(150) "Global contract research organization (CRO), Fortrea today announced an industry partnership with founding members cloud solutions company Veeva Syste"
  [3]=>
  string(213) "Global contract research organization (CRO), Fortrea today announced an industry partnership with founding members cloud solutions company Veeva Systems Inc., and provider of clinical research technology, Advarra."
  ["description"]=>
  string(213) "Global contract research organization (CRO), Fortrea today announced an industry partnership with founding members cloud solutions company Veeva Systems Inc., and provider of clinical research technology, Advarra."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(172) "https://www.outsourcing-pharma.com/Article/2024/01/10/fortrea-advarra-and-veeva-form-partnership-to-reduce-trial-burdens?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(172) "https://www.outsourcing-pharma.com/Article/2024/01/10/fortrea-advarra-and-veeva-form-partnership-to-reduce-trial-burdens?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-10 19:20:00"
  ["add_date"]=>
  string(19) "2024-01-10 19:20:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}